Anti-Tumour Effect of a Chitosan Delivery System for Doxorubicin
MetadataShow full item record
Used against a variety of tumours, doxorubicin (DOX), causes multiple side-effects in patients, especially in high doses required to control tumour growth. A drug delivery system (DDS) was developed to deliver DOX. Through DOX encapsulation into chitosan DDS, novel DOX microparticles (DMPs) were formed. Multiple optimisation steps produced DMPs which caused tumour cell death. Treatment of mice bearing tumours with DMP decreased tumour growth and spread, with no visible side-effects. There are plans to evaluate this delivery vehicle more closely towards clinical development and testing.
Showing items related by title, author, creator and subject.
Schaefer, Rainer (2008)At present, most cancers are treated with surgery, radiotherapy and chemotherapy, used alone or in combination. Surgery and radiotherapy are the primary treatment modalities after early detection of cancers and they ...
Microsphere distribution and radiation dosimetry in human liver following Yttrium-90 microsphere therapy.Campbell, Andrew M. (2000)The microscopic distribution of microspheres and the resulting radiation dose deposition patterns in human liver following hepatic arterial infusion of 90Y labelled microspheres have been investigated. Tissue samples from ...
New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasisClark, J.; Akiyama, T.; Dass, Crispin; Choong, P. (2010)Background: Chondrosarcoma responds poorly to adjuvant therapy and new, clinically relevant animal models are required to test targeted therapy. Methods: Two human chondrosarcoma cell lines, JJ012 and FS090, were evaluated ...